0000899243-20-015328.txt : 20200604 0000899243-20-015328.hdr.sgml : 20200604 20200604210201 ACCESSION NUMBER: 0000899243-20-015328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200604 FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thierer Mark CENTRAL INDEX KEY: 0001334925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38536 FILM NUMBER: 20944294 MAIL ADDRESS: STREET 1: DENTSPLY SIRONA INC STREET 2: 221 W PHILADELPHIA ST, STE 60W CITY: YORK STATE: PA ZIP: 17401-2991 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: SUITE 1600 CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 844-445-5704 MAIL ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: SUITE 1600 CITY: CHICAGO STATE: IL ZIP: 60601 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-04 0 0001346302 XERIS PHARMACEUTICALS INC XERS 0001334925 Thierer Mark C/O XERIS PHARMACEUTICALS, INC., 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 1 0 0 0 Stock Option (right to buy) 4.68 2020-06-04 4 A 0 11228 0.00 A 2030-06-04 Common Stock 11228 11228 D Such options will vest in full upon the earlier to occur of June 4, 2021 or the date of the Company's next annual meeting of stockholders. /s/ Beth Hecht, as Attorney-in-Fact 2020-06-04